Expression of K19 and K7 in dysplastic nodules and hepatocellular carcinoma.

Hepatocellular carcinoma (HCC) is one of the most common types of malignant tumors characterized by a multistep process of tumor development. Nodular lesions that differ from the surrounding liver parenchyma and are characterized by cytological or structural atypia are termed dysplastic nodules (DNs). DNs are well-known precancerous HCC lesions. Expression of keratin (K) 19 and K7, molecular markers of hepatic progenitor cells and cholangiocytes, has been reported in certain HCCs. However, it remains unclear whether K19-positive HCC cells are derived from true hepatic progenitor cells or mature cells that have undergone a dedifferentiation or a transdifferentiation process. In total, 107 tissue sections (13 low-grade DNs, 15 high-grade DNs, 27 small HCCs and 52 large HCCs) from resected liver samples and 132 HCC tissue microarray (TMA) cores were subjected to immunohistochemical analysis for K19 and K7. Clinicopathological data of the HCC patients were evaluated. K19 expression was found in 0% of DNs, 19% of small HCCs (≤2 cm), 8% of large HCCs (>2 cm) and 8% of TMA samples. K7 expression was found in 14% of DNs, 41% of small HCCs, 15% of large HCCs and 6% of TMA samples. Among the five K19-positive small HCCs, four were distinctly nodular and one tumor was an infiltrative type. No vaguely nodular HCC was positive for K19. K19 expression was significantly associated with histological grade (P=0.023), serum α-fetoprotein level (P=0.001) and K7 expression (P=0.001) in HCC. K19 expression was an independent prognostic factor for overall survival in non-viral HCC patients (P=0.003). K19 expression is extremely rare in DNs and occurs in progressed small HCCs. Our results suggest that K19 expression may be an acquired feature of carcinoma cells during HCC progression in certain HCCs.

[1]  Y. N. Park,et al.  Human hepatocellular carcinomas with “Stemness”‐related marker expression: keratin 19 expression and a poor prognosis , 2011, Hepatology.

[2]  K. Jang,et al.  Expression and role of SIRT1 in hepatocellular carcinoma. , 2011, Oncology reports.

[3]  B. Portmann,et al.  Mixed phenotype hepatocellular carcinoma after transarterial chemoembolization and liver transplantation , 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[4]  N. Enomoto,et al.  Expression of Keratin 19 Is Related to High Recurrence of Hepatocellular Carcinoma after Radiofrequency Ablation , 2011, Oncology.

[5]  Y. N. Park Update on precursor and early lesions of hepatocellular carcinomas. , 2011, Archives of pathology & laboratory medicine.

[6]  W. Lau,et al.  Hepatocellular Carcinoma Expressing Cholangiocyte Phenotype Is a Novel Subtype with Highly Aggressive Behavior , 2011, Annals of Surgical Oncology.

[7]  O. Matsui,et al.  Epidermal growth factor induces cytokeratin 19 expression accompanied by increased growth abilities in human hepatocellular carcinoma , 2011, Laboratory Investigation.

[8]  Y. Jeng,et al.  Role of p53 and β-catenin Mutations in Conjunction with CK19 Expression on Early Tumor Recurrence and Prognosis of Hepatocellular Carcinoma , 2011, Journal of Gastrointestinal Surgery.

[9]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[10]  O. Heidenreich,et al.  Understanding the cancer stem cell , 2010, British Journal of Cancer.

[11]  S. Qiu,et al.  High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinoma , 2010, Gut.

[12]  S. Thorgeirsson,et al.  Progenitor‐derived hepatocellular carcinoma model in the rat , 2010, Hepatology.

[13]  S. Morrison,et al.  Heterogeneity in Cancer: Cancer Stem Cells versus Clonal Evolution , 2009, Cell.

[14]  H. Honda,et al.  Biliary phenotype of hepatocellular carcinoma after preoperative transcatheter arterial chemoembolization , 2008, Journal of gastroenterology and hepatology.

[15]  L. Qin,et al.  Two pathologic types of hepatocellular carcinoma with lymph node metastasis with distinct prognosis on the basis of CK19 expression in tumor , 2008, Cancer.

[16]  G. Tseng,et al.  Mechanisms of hepatocyte growth factor–mediated and epidermal growth factor–mediated signaling in transdifferentiation of rat hepatocytes to biliary epithelium , 2008, Hepatology.

[17]  Y. Maehara,et al.  Histologic Characteristics and Prognostic Significance in Small Hepatocellular Carcinoma With Biliary Differentiation: Subdivision and Comparison With Ordinary Hepatocellular Carcinoma , 2007, The American journal of surgical pathology.

[18]  E. Lesaffre,et al.  The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin , 2006, Histopathology.

[19]  T. Yoshioka,et al.  Transdifferentiation of mature rat hepatocytes into bile duct-like cells in vitro. , 2005, The American journal of pathology.

[20]  J. Ferlay,et al.  Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.

[21]  M. Fiorentino,et al.  Partial Necrosis on Hepatocellular Carcinoma Nodules Facilitates Tumor Recurrence after Liver Transplantation , 2004, Transplantation.

[22]  Rong Zeng,et al.  From Proteomic Analysis to Clinical Significance , 2004, Molecular & Cellular Proteomics.

[23]  S. Kubo,et al.  Cytokeratin 19 expression in hepatocellular carcinoma predicts early postoperative recurrence , 2003, Cancer science.

[24]  Ronald Simon,et al.  Tissue microarrays for miniaturized high-throughput molecular profiling of tumors. , 2002, Experimental hematology.

[25]  V. Desmet,et al.  The immunohistochemical phenotype of dysplastic foci in human liver: correlation with putative progenitor cells. , 1999, Journal of hepatology.

[26]  F. Schaffner,et al.  Expression of cytokeratins in normal and diseased livers and in primary liver carcinomas. , 1989, Archives of pathology & laboratory medicine.

[27]  P. van Eyken,et al.  Cytokeratin expression in hepatocellular carcinoma: an immunohistochemical study. , 1988, Human pathology.

[28]  R. Warnke,et al.  The Diagnostic Utility of the Keratin Profiles of Hepatocellular Carcinoma and Cholangiocarcinoma , 1988, The American journal of surgical pathology.

[29]  Benjamin Geiger,et al.  The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cells , 1982, Cell.